Just over 10 years ago, Shinya Yamanaka, a stem-cell scientist at Japan’s Kyoto University, discovered that mature adult cells could be reprogrammed back into an… Read more
Nsight Barbara Nelsen on the business of science.
Rapid growth in the cell and gene therapy industry is driving the demand for more efficient and cost-effective manufacturing solutions. Last week, Cell and Gene… Read more
It’s no surprise that cell and gene therapies are a very hot topic in the biotech industry right now. But, did you know that right… Read more
On average, the cost of bringing a biologic therapy to market is $2.8 billion with a timeline of 10 years or more. As the biologics… Read more
As the cell therapy industry grows, so does the realization that biomanufacturing processes are critical to it’s clinical and commercial success. The challenge lies in that each… Read more